The interaction between RAGE gene polymorphisms and HPV infection in determining the susceptibility of cervical cancer in a Chinese population

Cancer Biomarkers

Volumn 11, Issue 4, 2012, Pages 147-153

  Xu, Qian ^a   Xue, Fengxia ^a   Yuan, Bibo ^a   Zhang, Linqin ^a   Li, Jie ^a   He, Zhaofang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

cervical cancer; Polymorphisms; risk; the receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84871605784     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-00277     Document Type: Article

References (29)

1. N. Behtash, N. Mehrdad, Cervical cancer: screening and prevention. Asian Pac J Cancer Prev 7 (2006) 683-686.
2. G. Ronco, C.J. Meijer, J. Cuzick, P. Giorgi-Rossi, J. Peto, N. Segnan, J. Dillner, Screening for Cervical Cancer. Ann Intern Med 156 (2012) 604-605.
3. T. Kanda, I. Kukimoto, [Human papillomavirus and cervical cancer]. Uirusu 56 (2006) 219-230.
4. S.F. Liao, W.C. Lee, H.C. Chen, L.C. Chuang, M.H. Pan, C.J. Chen, Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years. Cancer Causes Control (2012).
5. A.C. de Freitas, A.P. Gurgel, C.M. do Amaral, E.C. Coimbra, B.S. Chagas, Susceptibility to cervical cancer: An overview. Gynecol Oncol (2012).
6. H. Yamakawa, R. Konno, A. Enomoto, S. Netsu, S. Takahashi, M. Owada, M. Suzuki, [Prognostic factors of uterine cervical cancer]. Gan To Kagaku Ryoho 33 (2006) 2002-2007.
7. A.M. Schmidt, S.D. Yan, S.F. Yan, D.M. Stern, The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498 (2000) 99-111.
8. J.B. Lindsey, F. Cipollone, S.M. Abdullah, D.K. McGuire, Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): Cardiovascular implications. Diab Vasc Dis Res 6 (2009) 7-14.
9. B. Lu, X.L. Song, L.Y. Jia, F.L. Song, S.C. Zhao, Y. Jiang, [Differential expressions of the receptor for advanced glycation end products in prostate cancer and normal prostate]. Zhonghua Nan Ke Xue 16 (2010) 405-409.
10. M. Takada, K. Hirata, T. Ajiki, Y. Suzuki, Y. Kuroda, Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 51 (2004) 928-930. (Pubitemid 38822439)
11. K. Hirata, M. Takada, Y. Suzuki, Y. Kuroda, Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology 50 (2003) 1205-1207. (Pubitemid 37186445)
12. R. Jing, M. Cui, J. Wang, H. Wang, Receptor for advanced glycation end products (RAGE) soluble form (sRAGE):A new biomarker for lung cancer. Neoplasma 57 (2010) 55-61.
13. P. Tesarova, M. Kalousova, M. Jachymova, O. Mestek, L. Petruzelka, T. Zima, Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 25 (2007) 720-725. (Pubitemid 350223177)
14. H. Ishiguro, N. Nakaigawa, Y. Miyoshi, K. Fujinami, Y. Kubota, H. Uemura, Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64 (2005) 92-100. (Pubitemid 40734743)
15. L. Jiao, P.R. Taylor, S.J. Weinstein, B.I. Graubard, J. Virtamo, D. Albanes, R.Z. Stolzenberg-Solomon, Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 20 (2011) 1430-1438.
16. H. Gu, L.Yang, Q. Sun, B. Zhou, N. Tang, R. Cong, Y. Zeng, B. Wang, Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. Clin Cancer Res 14 (2008) 3627-3632.
17. T. Krechler, M. Jachymova, O. Mestek, A. Zak, T. Zima, M. Kalousova, Soluble receptor for advanced glycation endproducts (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem 43 (2010) 882-886.
18. P. Cinek, V. Stibor, [TNM classification of malignant ocular tumors]. Cesk Slov Oftalmol 60 (2004) 408-415. (Pubitemid 39578295)
19. M. Kalousova, M. Hodkova, M. Kazderova, J. Fialova, V. Tesar, S. Dusilova-Sulkova, T. Zima, Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis 47 (2006) 406-411. (Pubitemid 43255173)
20. Y.Y. Shi, L. He, SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97-98. (Pubitemid 41653949)
21. C.D. Logsdon, M.K. Fuentes, E.H. Huang, T. Arumugam, RAGE and RAGE ligands in cancer. Curr Mol Med 7 (2007) 777-789.
22. M.K. Fuentes, S.S. Nigavekar, T. Arumugam, C.D. Logsdon, A.M. Schmidt, J.C. Park, E.H. Huang, RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50 (2007) 1230-1240. (Pubitemid 47087458)
23. H. Kuniyasu, N. Oue, A. Wakikawa, H. Shigeishi, N. Matsutani, K. Kuraoka, R. Ito, H. Yokozaki, W. Yasui, Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196 (2002) 163-170. (Pubitemid 34110897)
24. A. Simm, B. Bartling, R.E. Silber, RAGE: a new pleiotropic antagonistic gene? Ann N Y Acad Sci 1019 (2004) 228-231. (Pubitemid 38951311)
25. K.H. Gaens, I. Ferreira, C.J. van der Kallen, M.M. van Greevenbroek, E.E. Blaak, E.J. Feskens, J.M. Dekker, G. Nijpels, R.J. Heine, L.M. t Hart, P.G. de Groot, C.D. Stehouwer, C.G. Schalkwijk, Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab 94 (2009) 5174-5180.
26. B.I. Hudson, M.H. Stickland, P.J. Grant, Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: Prevalence in type 2 diabetes and ethnic groups. Diabetes 47 (1998) 1155-1157. (Pubitemid 28294561)
27. M.A. Hofmann, S. Drury, B.I. Hudson, M.R. Gleason, W. Qu, Y. Lu, E. Lalla, S. Chitnis, J. Monteiro, M.H. Stickland, L.G. Bucciarelli, B. Moser, G. Moxley, S. Itescu, P.J. Grant, P.K. Gregersen, D.M. Stern, A.M. Schmidt, RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes Immun 3 (2002) 123-135. (Pubitemid 38961122)
28. Y. Jang, J.Y. Kim, S.M. Kang, J.S. Kim, J.S. Chae, O.Y. Kim, S.J. Koh, H.C. Lee, C.W. Ahn, Y.D. Song, J.H. Lee, Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56 (2007) 199-205. (Pubitemid 46074066)
29. P.S. de Araujo Souza, P.C. Maciag, K.B. Ribeiro, M.L. Petzl-Erler, E.L. Franco, L.L. Villa, Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 8 (2008) 246.